News for Healthier Living

Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy

A 41-year-old Silver Spring woman who has endured debilitating pain crises and frequent hospitalizations throughout much of her life as the result of sickle cell disease has been treated at the University of Maryland Medical Center (UMMC) with her own genetically engineered stem cells in an effort to prevent life-threatening complications and achieve a long-term cure.

April 29, 2026


May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026

May 7 2026

May 6 2026

May 5 2026

May 4 2026

May 1 2026

April 30 2026

April 29 2026